HAMP and Hepatic fibrosis: Our finding that hepcidin inhibits transforming growth factor β1 (TGFβ1)-mediated Smad3 phosphorylation by degrading FPN that is upregulated and responsible for the suppression of Akt signalling in activated HSCs, offers the novel therapeutic approaches to overcome liver fibrosis.